To include your compound in the COVID-19 Resource Center, submit it here.

Lilly, Novartis report 3Q17 results

Eli Lilly and Co. (NYSE:LLY) and Novartis AG (NYSE:NVS; SIX:NOVN) reported earnings on Tuesday which outpaced analyst expectations, and provided updates on their respective animal health and ophthalmic units.

Lilly reported

Read the full 310 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE